Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | Asia Pacific (Supplemental) | 2022

Growing AF treatment volumes, driven by an expanding patient pool, rising awareness of ablation procedures, and improving access to health care, will fuel strong growth in the Asia Pacific EP mapping and ablation device market through 2030. However, the COVID-19 global pandemic will have an impact on the Asia Pacific EP mapping and ablation device market, resulting in lost procedure volumes in the short term followed by a period of recovery. This is expected to reduce the growth of the EP mapping and ablation device market.

This Medtech 360 Report provides high-level market metrics for EP mapping and ablation devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 11-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Vascular Closure Devices – Market Insights – Global
The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedure volumes and by innovation associated with new products entering the market. Growth…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…